Literature DB >> 16510256

Initial studies of water granulation of eight grades of hypromellose (HPMC).

Jenny Herder1, Asa Adolfsson, Anette Larsson.   

Abstract

The purpose of this study is to investigate the water granulation mechanism of the hydrophilic matrix polymer HPMC in a high shear mixer and to relate the properties of the granules and tablets to the molecular weight and the degree of substitution for eight HPMC grades. Although the hydrophilic matrix system is a well known drug delivery one, there is a difficulty in that the desirable water granulation technique often causes problems in the presence of relatively large amounts of HPMC due to its hydrophilicity. The results of this study show that the properties of the granules and the tablets fall into two groups according to whether the molecular weight of the polymer is high or low. The granules of low molecular weight were smaller and more compact, with better flow properties but with less tensile strength of the compacts, whereas the opposite was valid for granules of high molecular weight. The explanation for these differences is linked to the proposed granulation mechanism of HPMC, in which the properties of the gel layer are important. The dominant factors governing the properties are the molecular weight and, to lesser extent, the degree of substitution.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16510256     DOI: 10.1016/j.ijpharm.2006.01.024

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

1.  Roller compaction of hydrophilic extended release tablets-combined effects of processing variables and drug/matrix former particle size.

Authors:  Johanna Heiman; Farhad Tajarobi; Bindhumadhavan Gururajan; Anne Juppo; Susanna Abrahmsén-Alami
Journal:  AAPS PharmSciTech       Date:  2014-10-02       Impact factor: 3.246

2.  Influence of Formulation Factors, Process Parameters, and Selected Quality Attributes on Carvedilol Release from Roller-Compacted Hypromellose-Based Matrix Tablets.

Authors:  Aleša Dular Vovko; Bor Hodžić; Tina Brec; Grega Hudovornik; Franc Vrečer
Journal:  Pharmaceutics       Date:  2022-04-16       Impact factor: 6.525

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.